Bridging the Gap From Soil to Oil
Disclaimer Dis claimer This presentation has been prepared by Nextleaf Solutions Ltd (“Nextleaf” or the “Company”). It does not purport to contain a ll the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the contents of this presentation, or any information provided in connection with it, as financial advice, financial product advice or advice relating to legal, taxation or investment matters. No representation or warranty (whether express or implied) is made by Nextleaf or any of its officers, advisers, agents or employees as to the accuracy, completeness or reasonableness of the information, statements, opinions or matters (express or implied) arising out of, contained in or derived from this presentation or provided in connection with it, or any omission from this presentation, nor as to the attainability of any estimates, forecasts or projections set out in this presentation. This presentation is provided expressly on the basis that you will carry out your own independent inquiries into the matters contained in the presentation and make your own independent decisions about the affairs, financial position or prospects of the Company. Nextleaf reserves the right to update, amend or supplement the information at any time in its absolute discretion (without incurring any obligation to do so). Neither Nextleaf, nor their respective related bodies corporate, officers, their advisers, agents and employees accept any responsibility or liability to you or to any other person or entity arising out of this presentation including pursuant to the general law (whether for negligence, under statute or otherwise), or under the Australian Securities and Investments Commission Act 2001, Corporations Act 2001, Competition and Consumer Act 2010 or any corresponding provision of any Australian state or territory legislation (or the law of any similar legislation in any other jurisdiction), or under similar provision under any applicable law including securities laws in Canada. Any such responsibility or liability is, to the maximum extent permitted by law, expressly disclaimed and excluded. Nothing in this material should be construed as either an offer to sell or a solicitation of an offer to buy or sell securities. It does not include all available information and should not be used in isolation as a basis to invest in Nextleaf. This presentation is not a prospectus, offering memorandum, or a public offering of securities. Nextleaf may offer common shares only to investors whom Nextleaf believes to be qualified to participate under registration and prospectus exemptions under applicable securities legislation. There is currently no public market for the resale of the common shares and such securities will be subject to restrictions under legislation that will vary depending upon the relevant jurisdiction. An investment in the company involves a high degree of risk and only investors who can reasonably afford a loss of their entire investment should consider purchasing shares. This presentation contains reference to certain intentions, expectations, future plans, strategy and prospects of Nextleaf. Those intentions, expectations, future plans, strategy and prospects may or may not be achieved. They are based on certain assumptions, which may not be met or on which views may differ and may b affected by known and unknown risks. The performance and operations of Nextleaf may be influenced by a number of factors, many of which are outside the control of the Company. No representation or warranty, express or implied, is made by the Company, or any of their respective directors, officers, employees, advisers or agents that any intentions, expectations or plans will be achieved either totally or partially or that any particular rate of return will be achieved. Given the risks and uncertainties that may cause Nextleaf actual future results, performance or achievements to be materially different from those expected, planned or intended, recipients should not place undue reliance on these intentions, expectations, future plans, strategy and prospects.
Disruptive Technology Nextleaf (CSE: OILS) owns a portfolio of issued and pending patents for the process of producing cannabinoid distillate, the precursor of every cannabis infused product Highly concentrated THC or CBD distillate is odourless, tasteless, and standardized for potency Nextleaf’s patented process will disrupt the production of infused edibles, vape pens, and beverages - legal in Canada by October 2019 Nextleaf commercializes its technology through toll processing and white label oils production.
Patented Extraction & Purification Process The flavours and aromas of cannabis are undesirable in edible and infused products made with crude extract due to chlorophyll, fats, lipids and other impurities Nextleaf has been issued a U.S. patent pertaining to the Company’s industrial-scale process of extraction and purification of cannabinoids The U.S. patent covers the process of transforming dried cannabis Through our into high-purity THC or CBD distillate oil, simplifying the patented technology, manufacturing of differentiated formulations and delivery methods we produce a premium, purified cannabinoid Health Canada’s draft regulations to legalize infused products by distillate October 2019 makes cannabinoid purification technology vital for the manufacturing of standardized edibles and vape pens
The secret to producing standardized and impurity free cannabis extracts is in the purification and refinement steps This goes above and beyond typical “crude extraction”, delivering a truly premium distillate THINK: PREMIUM VODKA VERSUS MOONSHINE
Intel Intellectu lectual al Pr Prope operty rty Po Portfo rtfolio lio Issued U.S. Patent: Patents Pending: NLU001: End-to-End Process NLU003: Process and system NLU004: Extraction using chilling system U.S. Patent scheduled to issue Q1 2019: NLU002: Cold Filtration Total of 18 patents pending in: United States, Canada, Mexico, Colombia, Jamaica, Europe, Australia
Turning ”Garbage” into Gold There is an ample supply of low-quality cannabis and hemp biomass and a lack of extraction and processing capacity in the industry Nextleaf provides processing to licensed cultivators, and supplies cannabis oil and extracts to qualified Canadian and international B2B partners under their own brand
Extracts: The Industry’s Fastest Growing Segment Nextleaf’s patented technology allows for low quality dried cannabis biomass, including failed crops, to be processed into high-purity distillate oil
Infused Products: In the Media Companies es that secure re unique e IP firs rst t will have a competi titive tive advantage ge . . IP categorie ies that a are most lucrative, e, are those that don’t relate to the actual plant, but to processing and pharmaceutical applications” – Financial Post Infused ed edible les and b beverages ges contain consist isten ent doses es of cannabis oil and h have a r reprod oducible ible effec fect, , while the e effec fects ts from m smoking ing cannabis can v vary widely ly. Edible les may co come with even higher demand.” – CBC News ws Six out of of 10 C Canadian customers ers would choose e pot edibles es over smokable les ” - Deloitt itte
Mo Mobile bile Extr Extractio action n Lab Lab The Mobile Lab travels to licensed production sites, operating under the client’s processing license Fully equipped to process 20 kg/hour of biomass into cannabis oil Through a toll processing model, Nextleaf has the Lab allows small producers to developed a first avoid the capital investment of of its kind, oil production Mobile Extraction Lab Exclusive manufacturing agreement with K-Line Trailers
Centr Ce ntraliz alized ed Pr Proces ocessing sing Facil Facility ity Toll processing and white-label oils production 6,540 sq. ft. processing facility in Greater Vancouver Capacity to process 100 tons of cannabis per year Research lab for testing and formulations 40 mins from Vancouver International Airport 9M sq. ft. of cannabis cultivation within 60 mins Standard Processor License expected Q2-Q3 2019
Pr Prod oduct uct Fo Formul rmulat atio ion Nextleaf develops proprietary formulations for infused products with THC and CBD distillate, significantly increasing speed-to-market for our B2B partners TOPICALS, SKINCARE SPECIALTY VAPE EDIBLE BEVERAGES & WATER-SOLUBLE EXTRACTS & TRANSDERMAL DELIVERY CONCENTRATES TECHNOLOGY OILS Letter of Intent Patent filed for Patented process Patent obtained for Letter of Intent (LOI) (LOI) signed with process to allows for easy dosing, tasteless, odourless signed with BevCanna Omni Bioceuticals concentrate resinous scalable production ingestible oil for supply of oils glands in the plant.
Recommend
More recommend
